|
GB201718284D0
|
|
Antibiotic compounds
|
|
GB201718285D0
|
|
Antibacterial Compounds
|
|
GB201708650D0
|
|
Combination therapy for bacterial infection
|
|
GB201614314D0
|
|
Antibiotic compounds
|
|
GB201511858D0
|
|
Antibiotic compounds
|
|
GB201507931D0
|
|
Combination therapies for combating resistance
|
|
GB201421854D0
|
|
Identifying genes involved in antibiotic resistance and sensitivity in bacteria using microcultures
|
|
GB201413198D0
|
|
Methods For Characterizing Bacterial Mutants
|
|
GB201413202D0
|
|
Process for producing bacterial mutants
|
|
GB201411358D0
|
|
Selective oligonucleotide probes and primers
|
|
GB201322084D0
|
|
Method for identifying genes involved in antibiotic resistance and sensitivity in gram-negative bacteria
|
|
GB201320410D0
|
|
Bacterial engineering with conditional mutator strains
|
|
GB201310080D0
|
|
Selective oligonucleotide probes and primers
|
|
WO2013175164A1
|
|
Characterization, classification and identification of microorganisms
|
|
GB201307683D0
|
|
Characterization, classification and identification of microorganisms
|
|
GB201219989D0
|
|
Bacterial engineering
|
|
GB201210013D0
|
|
Selecive oligonucleotide probes and primers
|
|
GB201209122D0
|
|
Characterization classification and identification of microorganisms
|
|
GB201208570D0
|
|
Antibiotic compounds
|
|
GB201208592D0
|
|
Antibiotic compounds
|
